IRIS - Res&Arch Institutional Research Information System - Research & Archive

MACCHIONI, Lara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.805
EU - Europa 3.024
AS - Asia 2.483
SA - Sud America 406
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
AN - Antartide 1
Totale 9.795
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.706
SG - Singapore 1.189
IE - Irlanda 519
IT - Italia 512
UA - Ucraina 393
CN - Cina 352
RU - Federazione Russa 323
BR - Brasile 321
SE - Svezia 319
HK - Hong Kong 311
DE - Germania 253
VN - Vietnam 196
FR - Francia 194
FI - Finlandia 169
KR - Corea 122
GB - Regno Unito 108
IN - India 74
RO - Romania 63
CA - Canada 56
TR - Turchia 41
IQ - Iraq 31
BD - Bangladesh 29
AR - Argentina 28
NL - Olanda 28
PL - Polonia 26
MX - Messico 24
CH - Svizzera 22
ZA - Sudafrica 22
BE - Belgio 21
ES - Italia 20
PK - Pakistan 20
UZ - Uzbekistan 19
EC - Ecuador 15
SA - Arabia Saudita 14
AT - Austria 13
ID - Indonesia 13
JP - Giappone 13
CL - Cile 10
KE - Kenya 10
CO - Colombia 9
MA - Marocco 9
PH - Filippine 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 7
LT - Lituania 7
MY - Malesia 7
TN - Tunisia 7
CZ - Repubblica Ceca 6
AZ - Azerbaigian 5
EG - Egitto 5
GR - Grecia 5
IL - Israele 5
PY - Paraguay 5
BO - Bolivia 4
DZ - Algeria 4
JM - Giamaica 4
NP - Nepal 4
PE - Perù 4
RS - Serbia 4
TT - Trinidad e Tobago 4
GT - Guatemala 3
JO - Giordania 3
KZ - Kazakistan 3
AL - Albania 2
AO - Angola 2
AU - Australia 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
EU - Europa 2
HU - Ungheria 2
LB - Libano 2
LV - Lettonia 2
MT - Malta 2
NI - Nicaragua 2
PS - Palestinian Territory 2
PT - Portogallo 2
TH - Thailandia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CG - Congo 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
IR - Iran 1
LY - Libia 1
MD - Moldavia 1
Totale 9.785
Salva come PNG Salva come JPEG
Città #
Singapore 858
Chandler 614
Dublin 519
Hong Kong 310
San Jose 310
Ashburn 292
San Mateo 216
Jacksonville 201
Perugia 186
Boardman 140
Santa Clara 122
Seoul 122
Munich 119
Ann Arbor 115
Moscow 113
Beijing 96
Medford 96
Princeton 96
Lauterbourg 86
Wilmington 76
Los Angeles 63
New York 62
Bucharest 57
Dong Ket 53
Redmond 53
Ho Chi Minh City 51
Altamura 49
Andover 49
Turku 40
Piscataway 39
Helsinki 36
Lawrence 32
Saint Petersburg 31
Hanoi 29
Montreal 27
Rome 27
Orem 25
Frankfurt am Main 24
Houston 24
São Paulo 24
Denver 23
Piediluco 23
Dallas 21
Izmir 21
Warsaw 21
Woodbridge 21
Brussels 20
Baghdad 19
Atlanta 18
Brooklyn 17
Stockholm 17
Amsterdam 16
Chennai 16
Johannesburg 16
London 16
Auburn Hills 15
Chicago 14
Milan 14
Norwalk 14
The Dalles 14
Falls Church 13
Mumbai 13
Des Moines 12
Tokyo 12
Manchester 11
Mexico City 10
Phoenix 10
Città Di Castello 9
Redwood City 9
Rio de Janeiro 9
Tashkent 9
Toronto 9
Boston 8
Falkenstein 8
Nairobi 8
Shanghai 8
Assisi 7
Belo Horizonte 7
Council Bluffs 7
Dhaka 7
Espoo 7
Ankara 6
Changsha 6
Guayaquil 6
New Delhi 6
Nuremberg 6
Ottawa 6
Shijiazhuang 6
Wuhan 6
Betim 5
Columbus 5
Grugliasco 5
Haiphong 5
Poplar 5
Querétaro 5
Santiago 5
Seattle 5
Agliana 4
Baku 4
Bắc Ninh 4
Totale 6.131
Salva come PNG Salva come JPEG
Nome #
Identification of a phosphatase activity, toward the phosphopeptide pyroGlu-Asp-Asp-Ser(p)-Asp-Glu-Glu-Asn, in nuclear extract from HL-60 promyelocitic leukaemia cells. 787
L’infiltrazione intradetrusoriale di tossina botulinica A riduce i livelli tissutali vescicali di nerve growth factor in pazienti affetti da iperattività detrusoriale neurogena. 220
Activation of human platelet phospholipase A2 induced by phisiological agonist or fluoroaluminate: effec of inhibitors of protein kinases 175
Characterization of nuclear secretory phospholipase A2 (sPLA2) 154
Activity, Expression, and Substrate Preference of the δ6-Desaturase in Slow- or Fast-Growing Rabbit Genotypes 149
Bromopyruvate mediates autophagy and cardiolipin degradation to monolyso-cardiolipin in GL15 glioblastoma cells 146
Clostridium difficile toxin B induces senescence in enteric glial cells: A potential new mechanism of Clostridium difficile pathogenesis 145
Selected cholesterol biosynthesis inhibitors produce accumulation of the intermediate FF-MAS that targets nucleus and activates LXRα in HepG2 cells 145
Acetamidine-based iNOS inhibitors as molecular tools to counteract inflammation in BV2 microglial cells 144
Palmitate lipotoxicity in enteric glial cells: Lipid remodeling and mitochondrial ROS are responsible for cyt c release outside mitochondria 141
Enteric glial cells are susceptible to Clostridium difficile toxin B 139
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 139
Studio di un'attività fosfolipasica presente nei nuclei di cellule gliali e neuronali di corteccia cerebrale di ratto. 138
Mitochondrial dysfunction and effect of antiglycolytic bromopyruvic acid in GL15 glioblastoma cells 137
Characterization of a phospholipase A2 present in purified nuclei from rat brain cortex . INTERNATIONAL CONFERENCE ON PHOSPHOLIPASE A2 136
Cytochrome c redox state influences the binding and release of cytochrome c in model membranes and in brain mitochondria 129
3-Bromopyruvate treatment induces alterations of metabolic and stress-related pathways in glioblastoma cells 129
Immunolocalization of secretory phospholipases A2 (sPLA2) in neural cells 125
The efficacy of the anticancer 3-bromopyruvate is potentiated by antimycin and menadione by unbalancing mitochondrial ROS production and disposal in U118 glioblastoma cells 124
Phospholipase A2 activity in rat brain nuclei. 122
Release of group IIA secretory phospholipase A2 from rat brain mitochondria: does it correlated with that of cytochrome c? 122
H2O2 disposal in cardiolipin-enriched mitochondria is due to increased cytochrome c peroxidase activity. 121
Cardiolipin-mediated temporal response to hydroquinone toxicity in human retinal pigmented epithelial cell line 120
RELEASE OF GROUP IIA SECRETORY PHOSPHOLIPASE A2 FROM RAT BRAIN MITOCHONDRIA: DOES IT CORRELATE WITH THAT OF CYTOCHROME c? 119
EFFECT OF NGF ON PHOSPHOLIPASES A2 LOCALIZATION IN PC12 CELLS 119
Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and/or the solution of a conundrum? 119
A Calsequestrin-1 mutation associated with a skeletal muscle disease alters sarcoplasmic Ca2+ release 117
Rat brain release a phospholipase A2 having properties similar those of the typr II secretory enzymes 115
Properties of phospholipase A2 in the nuclear fraction of rat brain cortex 114
Enteric glial cells counteract Clostridium difficile Toxin B through a NADPH oxidase/ROS/JNK/caspase-3 axis, without involving mitochondrial pathways 114
The presence of a secretory phospholipase A2 in the nuclei of neuronal and glial cells of rat brain cortex. 113
Crosstalk between long-term sublethal oxidative stress and detrimental inflammation as potential drivers for age-related retinal degeneration 113
Localisation and properties of Phospholipases A2 in rat brain cortex mithocondria assayed with labelled E.Coli membranes as substrates. 112
Botulinum A toxin intravesical treatment induces a reduction of nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. 112
Mitochondrial localization of sPLA2-IIA in neuronal cell 112
Tm7sf2 gene promotes adipocyte differentiation of mouse embryonic fibroblasts and improves insulin sensitivity 111
Bladder tissue levels of nerve growth factor in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 110
Cardiolipin contribution to H2O2 disposal in brain mitochondria 106
Characterization of a Phospholipases A2 present in purified nuclei from brain cortex 105
Cellular and subcellular distribution of secretory PLA2 in neural cells 104
Botulinum-A toxin injections into the detrusor muscle reduce nerve growth factor bladder tissue levels in patients affected by neurogenic detrusor overactivity. 104
Brain secretory phospholipase A2: functions and roles in neurodegenerative diseases 104
A channelopathy mutation in the voltage-sensor discloses contributions of a conserved phenylalanine to gating properties of Kv1.1 channels and ataxia 103
The release of arachidonic acid (AA ) by human platelets stimulated by fluoroaluminate and low concetration of collagene potentiated by inhibitors of protein kinase C (PKC). 102
BOTULINUM-A TOXIN INJECTIONS INTO THE DETRUSOR MUSCLE REDUCE NERVE GROWTH FACTOR BLADDER TISSUE LEVELS IN P A TIENTS AFFECTED BY NEUROGENIC DETRUSOR OVER- ACTIVITY 102
The energy blockers 3-bromopyruvate and lonidamine: effects on bioenergetics of brain mitochondria 102
Clostridium difficile Toxin b induces enteric glial cell death through ROS generation and activation of JNK 102
Down-regulation of fluoroaluminate-induced release of arachidonic acid by protein kinase C is calcium-dependent and not related to secretory phospholipase A2 101
Bladder tissue levels of NGF in SCI patients with detrusor overactivity before and after botulinum-A toxin injections into the detrusor muscle 101
Cytochrome c (cyt c) redox state and release from brain mitochondria: a H2O2-cardiolipin independent mechanism. 101
Bromopyruvate and Lonidamine against GL15 glioblastoma cells 101
Group B streptococcus (GBS) causes macrophage PLA2s activation and modification of phosphatidyl- serine metabolism during induction of apoptosis 100
Characterization of rat brain phospholipases A2 and their possible role in cellular signaling 99
Effect of NGF on phospholipase A2 localization in PC12 cells 98
Distribution of secretory phospholipase A2 (PLA2) in neural cells 98
CHARACTERIZATION OF NUCLEAR SECRETORY PHOSPHOLIPASE A2 (sPLA2) 97
Nerve Growth Factor bladder tissue levels in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 96
Determination of nerve growth factor levels into human bladder wall by modified enzyme-linked immunoabsorbent assay. 95
Brain secreted phospholipases A2 (sPLA2) as intra- and extra-cellular mediators 95
Brain mitochondrial phospholipases A2: functions and role in cell death 95
The energy blockers bromopyruvate and lonidamine lead GL15 glioblastoma cells to death by different p53-dependent routes 95
In vitro effect of nerve growth factor on the main traits of rabbit sperm 95
Brain secretory phospholipases A2: role in neurodegeneration. 93
Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity 93
Effect of dietary flaxseed supplementation on liver delta6-desaturase activity in two chicken genotypes 92
Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study 91
Subcellular localization of secretory phospholipases A2 (sPLA2) group IIA (GIIA) and group V (GV) in neural cells 91
Palmitate lipotoxicity in enteric glial cells 91
Presence of Group V Phospholipase A2 in rat brain cortex nuclei. 90
Maternal dietary supplementation of n-3 fatty acids: effect on ∆6-desaturase expression and activity of suckling rabbits 90
Is the cytosolic phospholipase A2 the enzyme that is activated by a G- protein-mediated mechanism in human platelets and is down-regulated by protein kinase C ? 88
Mitochondrial and nuclear secretory phospholipases A2: potential partecipation to life or death decision of neural cells. 88
Bladder tissue levels of NGF in SCI patients with detrusor overactivity before and after botulinum-A toxin injections into the detrusor muscle. 88
Presence of Group V Phospholipase A2 in rat brain cortex nuclei 88
Lethal digenic mutations in the K+channels kir4.1 (KCNJ10) and SLACK (KCNT1) associated with severe-disabling seizures and neurodevelopmental delay 87
Platelet-activating factor: role in long-term potentiation d in brain damage. 84
Impairment of brain mitochondrial functions by ß-hemolytic Group B Streptococcus. Effect of cardiolipin and phosphatidylcholine. 83
Differential protein expression in glioblastoma cells induced by 3-bromopyruvate 83
Nerve Growth factor bladder tissue levels in patients with neurogenic detrusor overactivity before and after botulinum-A toxin injections into the detrusor muscle 82
Release of a phospholipase a2 from rat brain mithocondria. 82
Impairment of brain mitochondrial functions by β-hemolytic Group B Streptococcus. Effect of cardiolipin and phosphatidylcholine 80
Identification of a phosphatase activity, toward the phosphopeptide PyroGlu-Asp-Asp-Ser(p)-Asp-Glu-Glu-Asn, in nuclear extract from HL-60 promyelocitic leukaemia cells. 78
Platelet-activating factor: role in long-term potentiation and in brain damage 77
Evidence that cytosolic phospholipase A2 is down-regulated by protein kinase C in intact human platelets stimulated with fluoroaluminate. 73
Determination of Nerve Growth Factor levels into human bladder wall by modified enzyme-linked immunoabsorbent assay. 72
Role of protein kinase C in the release of arachidocic acid from platelets 72
Long-term effects of silver nanoparticles on reproductive activity of rabbit buck 71
Respiratory state and release of mitochondrial phospholipase A2 69
Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases. 69
Livelli tissutali di Nerve growth factor nella ipertrofia prostatica benigna ed iperattività detrusoriale dopo terapia con tamsulosina. 68
Phospholipase A2 release from rat brain cortex mitochondria depends on respiratory state and precedes the liberation of cytochrome c 67
Release of secretory typeII phospholipase A2 from rat brain cortex mitochondria depends on respiratory state 65
Rat brain cortex mitochondria release group II secretory phospholipase A(2) under reduced membrane potential. 64
Livelli tissutali vescicali di Nerve Growth Factor nella Ipertrofia Prostatica Benigna ed iperattività detrusoriale dopo terapia con Tamsulosina. 63
Localizzazione e proprietà delle fosfolipasi A2 nelle frazioni subcellulari della corteccia cerebrale di ratto 59
NERVE GROWTH FACTOR BLADDER TISSUE LEVELS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND DETRUSOR OVER ACTIVITY TREATED WITH TAMSULOSIN 55
Localization and effect of ammodytoxin in PC12 cells. 51
Evaluation of the gene expression and Δ6-desaturase activity in different chicken strains 38
Molecular and functional characterization of GMP-manufactured neural stem cells and their extracellular vesicles for innovative therapeutic applications 28
null 27
Totale 10.818
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.483
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021187 0 0 0 0 0 0 0 0 0 41 71 75
2021/20221.697 19 908 18 59 38 7 17 221 11 115 132 152
2022/20231.632 111 230 16 172 129 158 4 94 643 4 52 19
2023/2024639 40 53 34 8 16 7 188 24 66 11 111 81
2024/20251.527 49 148 64 106 175 66 61 110 279 83 241 145
2025/20263.253 219 217 171 569 453 308 496 176 396 248 0 0
Totale 10.818